The relationship between epidermal growth factor receptor (EGFR) status and various prognostic factors was investigated in 70 human breast cancer specimens. Epidermal growth factor receptor was determined by radioligand binding assay, standardized by the EORTC Receptor Study Group, using hydroxyapatite to separate receptor-bound and free ligand. The percentage of EGFR positivity was 80% when the cutoff was set at 5 fmol/mg of membrane protein; this percentage was among the highest hitherto reported. Regression analysis of EGFR versus ER and PR levels confirmed an inverse relationship between EGFR and ER (p = 0.022) as well as between EGFR and PR (p = 0.024). Univariate analysis of the EGFR data stratified according to steroid hormone receptor status showed EGFR to be negatively associated with ER and PR. No association was found between EGFR and menopausal status, axillary lymph node involvement, tumor size, and differentiation grade. A direct association between EGFR status and Ki-67 positive cell rate could be demonstrated.
BloomH.J.G., RichardsonW.W.Histologic grading and prognosis in breast cancer.A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer1957; 11: 359–77.
2.
SayC.C., DoneganW.L.Invasive carcinoma of the breast: Prognostic significance of tumor size and involved axillary lymph nodes.Cancer1974; 34: 486–71.
3.
HeryM., GioannJ., LalanneC.M., CourdiaA.The DNA labelling: A prognostic factor in node negative breast cancer.Breast Cancer Res Treat1987; 9: 207–11.
4.
McGuireW.L.Steroid receptors in human breast cancer.Cancer Res1978; 38: 4289–91.
5.
ClarkG.M., McGuireW.L., HubayC.H.A., PearsonO.H., MarshallJ.S.Progesterone receptors as a prognostic factor in stage II breast cancer.N Engl J Med1983; 22: 1343–7.
6.
SalomonD.S., KidwellW.R.Tumor-associated growth factor in malignant rodent and human mammary epithelial cells. In: McGuireW.L., LippmanM.E., DicksonR.B. eds. Breast cancer: Cellular and molecular biology.Boston: Kluver, 1988; 363–91.
7.
FitzpatrickS.L., BrightwellJ., WitliffJ.L., GeorgeH.B., SchultzG.S.Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.Cancer Res1984; 44: 3448–53.
8.
MaciasA., AzavedoE., HaegerstroemT., KlinterbergC., PerezR., SkoogL.Prognostic significance of the receptor for epidermal growth factor in human mammary carcinomas.Anticancer Res1988; 7: 459–63.
9.
DownwardJ., YardenY., MayesE.Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.Nature1984; 307: 521–7.
10.
BargmannC.I., HungM.C., WeinbergR.A.The neu oncogene encodes an epidermal growth factor receptor-related protein.Nature1986; 319: 226–30.
11.
PfeifferD., StellwiB., PfeifferA., BorlinghausP., MeyerW., ScheidelP.Clinical implication of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix.Gynecol Oncol1989; 33: 146–50.
12.
GullickW.J., MarsdenJ.J., WhittleN., WardB., BorrowL.M., WaterfieldM.D.Expression of epidermal growth factor receptors on human cervical, ovarian and vulvar carcinomas.Cancer Res1986; 46: 285–92.
13.
BergerM.S., GreenfieldC., GullickW.J.Evaluation of epidermal growth factor receptors in bladder tumors.Br J Cancer1987; 56: 533–7.
14.
WongA.J., BignerS.H., BignerD.D., KinzlerK.W., HamiltonS.T., VogelsteinB.Increased expression of the epidermal growth factor receptor gene in malignant glioma is invariably associated with gene amplification.Proc Nat Acad Sci (Wash.)1987; 84: 6899–903.
15.
LuS.H., HsiehL.L., LuoF.C., WeinsteinI.B.Amplification of the EGF receptor and c-myc genes in human esophageal cancer.Int J Cancer1988; 42: 502–5.
16.
YasuiW., SumiyoshiH., HataJ.Expression of epidermal growth factor receptor in human gastric and colonic carcinomas.Cancer Res1988; 48: 137–41.
17.
HwangD.L., TayY.C., LinS.S., Lev-RanA.Expression of epidermal growth factor receptors in human lung tumors.Cancer1986; 58: 2260–3.
18.
SainsburyI.R.C., FarndonJ.R., NeedhamG.K., MalcomA.J., HarrisA.L.Epidermal growth factor receptor status as predictor of early recurrence and death from breast cancer.Lancet1987; 1: 1398–402.
19.
SainsburyJ.R.C., NicholsonS., AngusB., FarndonJ.R., MalcomA.J., HarrisA.L.Epidermal growth factor receptor status of histological subtypes of breast cancer.Br J Cancer1988; 58: 458–60.
20.
RiosM.A., MaciasA., PerezR., LageA., SkoogL.Receptors for epidermal growth factor and estrogen as predictors of relapse in patients with mammary carcinoma.Anticancer Res1988; 8: 173–6.
21.
SainsburyJ.R.C., FarndonJ.R., SherbertG.V., HarrisA.L.Epidermal growth factor receptors and estrogen receptors in human breast cancer.Lancet1985; 1: 364–8.
22.
NicholsonS., HalcrowP., SainsburyJ.R.C.Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer.Br J Cancer1988; 58: 810–4.
23.
KoendersP.G., FaverlyD., BeaxLVAM, BrugginkE.D.M., KienhuisC.B.M., BenraadT.J.Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology.Eur J Cancer1992; 28: 693–7.
24.
KlijnJ.G.M., BernsPMJJ, SchmitzP.I.M., FoekensJ.A.The clinical significance of epidermal growth factor receptor (EGR-R) in human breast cancer: a review on 5232 patients.Endocrine Rev1992; 13: 3–17.
25.
EORTC Breast Cancer Cooperative Group.Revision of standards for the assessment of hormone receptors in human breast cancer.Eur J Cancer1980; 16: 1513–5.
26.
BenraadT.J., FoekensJ.A.Hydroxyapatite assay to measure epidermal growth factor receptor in human primary breast tumors.Ann Clin Biochem1990; 27: 272–3.
27.
ScatchardG.The attraction of proteins for small molecules and ions.Ann NY Acad Sci1949; 51: 660–72.
28.
BradfordM.M.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem1976; 72: 248–54.
29.
HartmannW.H., OzzelloL., SobinL.H., StalsbergH.Histological typing of breast tumors.International histological classification of tumors.2nd edition, Geneva: WHO, 1981.
30.
HermanekP., SobinL.H.TNM-classification of malignant tumors.4th edition, Geneva: UICC, 1987.
31.
BlackM.M., SpeerF.D.Nuclear structure in cancer tissue.Surg Gynecol Obstet1957; 105: 97–102.
32.
GerdesJ., LemkeH., BaischH., WackerH.H., SchwabU., SteinH.Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67.J Immunol1983; 133: 1710–5.
DixonW.J.BMDP statistical software manual.Berkeley: University of California Press, 1992.
35.
ToiM., OsakiA., YamadaH., TogeT.Epidermal growth factor receptor expression as a prognostic indicator in breast cancer.Eur J Cancer1991; 27: 977–80.
36.
GrimauxM., RomainS., RemvikosY., MartinP.M., MagdelenatH.Prognostic value of epidermal growth factor receptor in node positive breast cancer.Breast Cancer Res Treat1989; 14: 77–90.
37.
FoekensJ.A., PortengenH., Van PuttenW.L.J.Prognostic value of receptors for insulin like growth factor 1, somatostatin and epidermal growth factor in human breast cancer.Cancer Res1989; 49: 7002–9.
38.
LewisS., LockerA., ToddJ.H.Expression of epidermal growth factor receptor in breast carcinoma.J Clin Pathol1990; 43: 385–9.
39.
SpyratosF., DelarneJ., AndrienC.Epidermal growth factor receptors and prognosis in primary breast cancer.Breast Cancer Res Treat1990; 17: 83–9.
40.
DittadiR., DionisiP.M., BrazzaleA., CappellozzaL., BruscagninG., GionM.Epidermal growth factor receptor in breast cancer.Comparison with non malignant breast tissue. Br J Cancer1993; 67: 7–9.
41.
PerezR., PascualM., MaciasA., LageA.Epidermal growth factor receptors in human breast cancer.Breast Cancer Res Treat1984; 4: 189–93.
42.
ToiM., NakamuraT., MukaidaH.Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer.Cancer1990; 65: 1980–4.
43.
CappellettiV., BrivioM., MiodiniP., GranataG., CaradiniD., Di FronzoG.Simultaneous estimation of epidermal growth factor receptors and steroid receptors in a series of 136 resectable primary breast tumors.Tumor Biol1988; 9: 200–11.
44.
KoendersP.G., BeexLVAM, Geurts-MoespotA., HenrelJJTM, KienhuisC.B.M., BenraadT.J.Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers.Cancer Res1991; 51: 4544–8.
